CAS 95716-98-6

Formule : C24H31KO7

InChI : InChI=1S/C24H32O7.K/c1-21-7-4-14(25)10-13(21)11-15(20(28)30-3)19-16-5-8-23(29,9-6-18(26)27)22(16,2)12-17-24(19,21)31-17;/h10,15-17,19,29H,4-9,11-12H2,1-3H3,(H,26,27);/q;+1/p-1/t15-,16+,17-,19+,21+,22+,23-,24-;/m1./s1

Code InChI : PRKXKJMKEHYPBV-PUDZRVQSSA-M

SMILES : C[C@]12CCC(=O)C=C1C[C@H]([C@@H]3[C@]24[C@H](O4)C[C@]5([C@H]3CC[C@]5(CCC(=O)[O-])O)C)C(=O)OC.[K+]

Eplerenone EP Impurity F Potassium salt

CAS : 95716-98-6

Formule : C₂₄H₃₁O₇·K

Couleur et forme : White To Off-White Solid

Masse moléculaire : 431.51 39.10

Ref: 4Z-E-131

9,11α-Epoxy-17-hydroxy-7α-(methoxycarbonyl)-3-oxo-17α-pregn-4-ene-21-carboxylic Acid Potassium Salt

CAS : 95716-98-6

Formule : C₂₄H₃₁O₇·K

Couleur et forme : Neat

Masse moléculaire : 470.6

Ref: 86-MM3530.07

Eplerenone Hydroxyacid Potassium Salt

Produit contrôlé

CAS : 95716-98-6

Applications A metabolite of Eplerenone. Used in combination therapy for treatment of cardiovascular disorders.
References Staessen, J., et al.: J. Endocrinol., 91, 457 (1981), de Gasparo, M., et al.: J. Pharmacol. Exp. Ther., 240, 650 (1987), MacFadyen, R., et al.: Cardiovasc. Res., 35, 30 (1997),

Formule : C₂₄H₃₁O₇·K

Couleur et forme : Neat

Masse moléculaire : 470.6

Ref: TR-E588780

Eplerenone-methyl-d3 Hydroxyacid Potassium Salt

Produit contrôlé

CAS : 95716-98-6

Applications A labelled metabolite of Eplerenone. Used in combination therapy for treatment of cardiovascular disorders.
References Staessen, J., et al.: J. Endocrinol., 91, 457 (1981), de Gasparo, M., et al.: J. Pharmacol. Exp. Ther., 240, 650 (1987), MacFadyen, R., et al.: Cardiovasc. Res., 35, 30 (1997),

Formule : C₂₄D₃H₂₈KO₇

Couleur et forme : Neat

Masse moléculaire : 473.615

Ref: TR-E588782

Eplerenone hydroxyacid potassium salt

CAS : 95716-98-6

Eplerenone is a drug that belongs to the class of drugs known as selective mineralocorticoid receptor antagonists. It is a prodrug that is metabolized in vivo to its active form, eplerenone acid. Eplerenone inhibits the binding of aldosterone to its receptors in the kidney. Eplerenone hydroxyacid potassium salt has been shown to have stereochemical purity of >98% and no detectable process-related impurities or experimental impurities. High-performance liquid chromatography (HPLC) methods have been used to characterize this drug substance and confirm that it has an average particle size 10 micrometers with no particles > 150 micrometers.

Formule : C₂₄H₃₁KO₇

Degré de pureté : Min. 95%

Masse moléculaire : 470.6 g/mol

Ref: 3D-FE22748